Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Biosensors (Basel) ; 12(8)2022 Jul 29.
Article in English | MEDLINE | ID: covidwho-2023154

ABSTRACT

Currently, several biosensors are reported to confirm the absence/presence of an abnormal level of specific human biomarkers in research laboratories. Unfortunately, public marketing and/or pharmacy accessibility are not yet possible for many bodily fluid biomarkers. The questions are numerous, starting from the preparation of the substrates, the wet/dry form of recognizing the (bio)ligands, the exposure time, and the choice of the running buffers. In this context, for the first time, the present overview summarizes the pre-functionalization of standard and nanostructured solid/flexible supports with cysteamine (Cys) and glutaraldehyde (GA) chemicals for robust protein immobilization and detection of biomarkers in body fluids (serum, saliva, and urine) using three transductions: piezoelectrical, electrochemical, and optical, respectively. Thus, the reader can easily access and compare step-by-step conjugate protocols published over the past 10 years. In conclusion, Cys/GA chemistry seems widely used for electrochemical sensing applications with different types of recorded signals, either current, potential, or impedance. On the other hand, piezoelectric detection via quartz crystal microbalance (QCM) and optical detection by surface plasmon resonance (LSPR)/surface-enhanced Raman spectroscopy (SERS) are ultrasensitive platforms and very good candidates for the miniaturization of medical devices in the near future.


Subject(s)
Biosensing Techniques , Cysteamine , Biomarkers , Biosensing Techniques/methods , Cysteamine/chemistry , Glutaral , Humans , Quartz Crystal Microbalance Techniques , Surface Plasmon Resonance
2.
Biosens Bioelectron ; 192: 113484, 2021 Nov 15.
Article in English | MEDLINE | ID: covidwho-1293597

ABSTRACT

Real-time reverse transcriptase-polymerase chain reaction (RT-PCR)-based assays are the gold standard for virus diagnosis. Point-of-care (POC) technologies have shown great progress during this period. Herein, we propose a novel fuchsine dye-loaded polymersome for a colorimetric paper-based dot blot spike protein diagnostic assay for COVID-19 via smartphone-assisted sensing. The prepared platform aimed to create an adaptable tool that competes with traditional nanoparticle-based assays employing gold and silver. Analytical characterization and application of the testing platform showed high sensitivity (10 times better than gold nanoparticles), stability, fast turnaround, and reproducibility. The potential and possibilities demonstrated by the current platform could be observed in its adaptability for different markers and pathologies. In addition, smartphone-assisted sensing emphasizes the ability to use the tool at home by common peoples which can lower the burden on the healthcare facilities and reach more underdeveloped regions.


Subject(s)
Biosensing Techniques , COVID-19 , Spike Glycoprotein, Coronavirus/analysis , COVID-19/diagnosis , Gold , Humans , Metal Nanoparticles , Reproducibility of Results , Rosaniline Dyes , SARS-CoV-2 , Sensitivity and Specificity
3.
Biomaterials ; 273: 120824, 2021 06.
Article in English | MEDLINE | ID: covidwho-1184843

ABSTRACT

Sponge particulates have attracted enormous attention in biomedical applications for superior properties, including large porosity, elastic deformation, capillary action, and three-dimensional (3D) reaction environment. Especially, the tiny porous structures make sponge particulates a promising platform for drug delivery, tissue engineering, anti-infection, and wound healing by providing abundant reservoirs of broad surface and internal network for cargo shielding and shuttling. To control the sponge-like morphology and improve the diversity of drug loading, some optimized preparation techniques of sponge particulates have been developed, contributing to the simplified preparation process and improved production reproducibility. Bio-functionalized strategies, including target modification, cell membrane camouflage, and hydrogel of sponge particulates have been applied to modulate the properties, improve the performance, and extend the applications. In this review, we highlight the unique physical properties and functions, current manufacturing techniques, and an overview of spongy particulates in biomedical applications, especially in inhibition of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity. Moreover, the current challenges and prospects of sponge particulates are discussed rationally, providing an insight into developing vibrant fields of sponge particulates-based biomedicine.


Subject(s)
COVID-19 , Precision Medicine , Drug Delivery Systems , Humans , Porosity , Reproducibility of Results , SARS-CoV-2
4.
Biosens Bioelectron ; 166: 112471, 2020 Oct 15.
Article in English | MEDLINE | ID: covidwho-670678

ABSTRACT

The infection and spread of pathogens (e.g., COVID-19) pose an enormous threat to the safety of human beings and animals all over the world. The rapid and accurate monitoring and determination of pathogens are of great significance to clinical diagnosis, food safety and environmental evaluation. In recent years, with the evolution of nanotechnology, nano-sized graphene and graphene derivatives have been frequently introduced into the construction of biosensors due to their unique physicochemical properties and biocompatibility. The combination of biomolecules with specific recognition capabilities and graphene materials provides a promising strategy to construct more stable and sensitive biosensors for the detection of pathogens. This review tracks the development of graphene biosensors for the detection of bacterial and viral pathogens, mainly including the preparation of graphene biosensors and their working mechanism. The challenges involved in this field have been discussed, and the perspective for further development has been put forward, aiming to promote the development of pathogens sensing and the contribution to epidemic prevention.


Subject(s)
Bacteria/isolation & purification , Betacoronavirus/isolation & purification , Biosensing Techniques/methods , Clinical Laboratory Techniques/methods , Coronavirus Infections/diagnosis , Graphite , Pandemics , Pneumonia, Viral/diagnosis , Viruses/isolation & purification , Animals , Bacteria/genetics , Bacteria/pathogenicity , Betacoronavirus/genetics , Betacoronavirus/pathogenicity , COVID-19 , COVID-19 Testing , Graphite/chemistry , Humans , Molecular Diagnostic Techniques , Nanotechnology , SARS-CoV-2 , Viruses/genetics , Viruses/pathogenicity
SELECTION OF CITATIONS
SEARCH DETAIL